Similar to symptomatic CAD, patients with confirmed PAD who are treated with antiplatelet and possible anticoagulant drugs, are characterized by increased levels of sP-selectin (95–99), sCD40L (98), and sGPV (84) compared to healthy volunteers (Table 2, Supplementary Table 1). The gene discussed is CD40LG; the disease is peripheral arterial disease.